Showing results (11-20 of 648) with videos related to

Sort By:
Pageof 65
Journal of Immunological Methods|January 20, 1998
Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic interaction chromatographyO Manzke, H Tesch, V Diehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Current clinical trials in Hodgkin's diseaseK Reuss, A Engert, H Tesch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Lymphocyte predominant Hodgkin's disease: pathology and clinical implicationJ Franklin, H Tesch, M L Hansmann, et al.
Leukemia & Lymphoma|August 1, 1992
Analysis of c-myc, bcl-1 and bcl-2 translocations in human lymphoma by pulsed-field gel electrophoresisK Koch, H Tesch, S Eidt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1995
Serum cytokine levels correlate with clinical parameters in Hodgkin's diseaseM Gorschlüter, H Bohlen, D Hasenclever, et al.
International Journal of Cancer|March 17, 2001
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. II. Assessment of cellular immune responsesO Manzke, H Tesch, J Lorenzen, et al.
Bone Marrow Transplantation|August 10, 2000
Treatment of patients with malignant lymphomas with monoclonal antibodiesH Tesch, A Engert, O Manzke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG)C Engel, M Loeffler, S Schmitz, et al.
International Journal of Oncology|May 17, 2011
Analysis of protooncogenes in squamous-cell carcinomas of the head and neck (scchn)P Volling, M Jungehulsing, H Stutzer, et al.
Annals of Hematology|May 10, 2000
Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's diseaseH Bohlen, M Kessler, M Sextro, et al.
Pageof 65